X0306 4 2019-02-19 0 0001649989 Outlook Therapeutics, Inc. OTLK 0001230484 KENYON LAWRENCE A C/O OUTLOOK THERAPEUTICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512 1 1 0 0 CEO, Pres, CFO, Treas & Secy Stock Option (Right to Buy) 1.32 2019-02-19 4 A 0 800000 0.00 A 2029-02-19 Common Stock 800000 800000 D The shares underlying the option shall vest in four equal installments beginning on February 19, 2020 such that the option shall be vested in full on February 19, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date. Vesting may be accelerated in the event of (a) a change in control as defined in the Issuer's 2015 Equity Incentive Plan and (b) the achievement of certain pre-defined corporate objectives, in each case subject to the Reporting Person providing continuous service to the Issuer through such event. /s/ Lawrence Kenyon 2019-02-19